Aurinia Pharmaceuticals
AUPH
AUPH
144 hedge funds and large institutions have $946M invested in Aurinia Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 67 increasing their positions, 29 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
11% more funds holding
Funds holding: 130 → 144 (+14)
0.7% less ownership
Funds ownership: 52.1% → 51.4% (-0.7%)
1% less capital invested
Capital invested by funds: $953M → $946M (-$6.72M)
Holders
144
Holding in Top 10
5
Calls
$38M
Puts
$30.8M
Top Buyers
1 | +$52.4M | |
2 | +$38M | |
3 | +$36.6M | |
4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$23.6M |
5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$16.1M |
Top Sellers
1 | -$75.1M | |
2 | -$27.1M | |
3 | -$22.1M | |
4 |
![]()
Franklin Resources
San Mateo,
California
|
-$16.7M |
5 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$15.9M |